Logo-bi
Letter to the Editor
Morteza Mahmoudi* ORCID, Sherry Moss ORCID, Loraleigh Keashly
Bioimpacts. 2022;12(1): 1-2. doi: 10.34172/bi.2021.44
Graphical Abstract
Dr. Morteza Mahmoudi is an Assistant Professor of Radiology and Precision Health Program at Michigan State University (MSU). His specific research interest is in nanomedicine and regenerative medicine for the development of new nano-based platforms for prevention/treatment of life-threatening conditions.
Mini Review
Mohammad A. Rafi* ORCID
Bioimpacts. 2022;12(1): 3-7. doi: 10.34172/bi.2021.23931
Graphical Abstract
Cutting viral dose in half or using BM cells from heterozygote mice in a combination of BMT and gene therapy treatments result in a similar reduction in lifespan of the treated mice.
Review
Luigi X Cubeddu* ORCID, Daisy de la Rosa, Michele Ameruoso
Bioimpacts. 2022;12(1): 9-20. doi: 10.34172/bi.2021.23630
Graphical Abstract
A combination of old age, comorbidities, increased cytokine levels and proarrhythmic drug therapies canexplain the increased arrhythmic events reported in severe COVID-19 disease.
Original Research
Fatemeh Khonsari ORCID, Mostafa Heydari ORCID, Rassoul Dinarvand ORCID, Mohammad Sharifzadeh ORCID, Fatemeh Atyabi* ORCID
Bioimpacts. 2022;12(1): 21-32. doi: 10.34172/bi.2021.23389
Graphical Abstract
Nanostructured-Lipid-Carriers (NLCs) for brain delivery of rapamycin were designed by modification of optimized cationic-NLCs (C-NLC) with different approaches. The targeted transferrin decorated NLCs(Tf-NLCs) in comparison to untargeted bare-NLCs (B-NLCs) showed higher cellular uptake and appropriate targeted accumulation in the brain.
Original Research
Mozhgan Fatahi Dehpahni ORCID, Khosrow Chehri* ORCID, Mehri Azadbakht ORCID
Bioimpacts. 2022;12(1): 33-42. doi: 10.34172/bi.2021.22037
Graphical Abstract
Aerobic vaginitis is a mixed infection caused by aerobic bacteria. This type of vaginitis model was established in mice by Escherichia coli and Staphylococcus aureus and evaluated the effect of silver nanoparticles and L carnitine in their treatment.
Original Research
Bambang Kuswandi* ORCID, Nur Andriani, Ari S Nugraha
Bioimpacts. 2022;12(1): 43-50. doi: 10.34172/bi.2021.41
Graphical Abstract
A wearable smart woman pad is developed for pH and urea detection in mensuration blood samples that integrated with thread-paper microfluidic devices (μTPAD). Here a threaded part for the whole blood handling, while a paper part for the analyte detection.
Original Research
Nadezhda V. Maksimova ORCID, Anna V. Michenko, Olga A. Krasilnikova ORCID, Ilya D. Klabukov* ORCID, Igor Yu. Gadaev ORCID, Michael E. Krasheninnikov ORCID, Pavel A. Belkov, Aleksey V. Lyundup ORCID
Bioimpacts. 2022;12(1): 51-55. doi: 10.34172/bi.2021.22167
Graphical Abstract
Three-year follow-up of patients, treated for diabetic foot ulcers with mesenchymal stromal cells that revealed absence of ulcer recurrence, neoplasms, and scar contracture. Collagen ultrasound density decreased by 57% and the epidermal thickness increased by 72% in the area of healed ulcers.
Original Research
Zahra Olfat Noubari ORCID, Asal Golchin, Marziyeh Fathi* ORCID, Ailar Nakhlband* ORCID
Bioimpacts. 2022;12(1): 57-64. doi: 10.34172/bi.2021.23831
Graphical Abstract
The prepared CS-based hydrogels with desired properties including porous structure, high swelling ability, and cytocompatibility did not show oxidative stress for the nesting of stem cells.
Original Research
Efthymia-Iliana Matthaiou ORCID, Yi Guo, Jaleh Barar ORCID, Raphael Sandaltzopoulos, Lana E. Kandalaft, Chunsheng Li*, George Coukos, Yadollah Omidi* ORCID
Bioimpacts. 2022;12(1): 65-86. doi: 10.34172/bi.2021.23511
Graphical Abstract
Poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs) functionalized with polyethylene glycol (PEG)and anti-TEM1 antibody fragment (78Fc) and loaded with necrosis-inducing agent shikonin (SHK)(78Fc-PLGA-SHK NPs) is a highly effective immunostimulating nanomedicine against theTEM1-expressing cells for targeted therapy of solid tumors.

BioImpacts, as a peer-reviewed international journal, publishes all types of papers on bench-to-bedside translational aspects of pharmaceutical and biomedical sciences. As a "Publish Free" and "Access Free" journal, BioImpacts follows a constructive peer-review process with free editing service to benefit the scientific community worldwide.